EUVIMEDSkopri EUVIMED
BeobachtungsstudieOpen access

Validity of a Consumer-Based Wearable to Measure Clinical Parameters in Patients With Chronic Obstructive Pulmonary Disease and Healthy Controls: Observational Study

Validität eines verbraucherbasierten Wearables zur Messung klinischer Parameter bei Patient:innen mit chronisch obstruktiver Lungenerkrankung und gesunden Kontrollen: Beobachtungsstudie

Fien Hermans iD, Eva Arents iD, Astrid Blondeel iD, Wim Janssens iD, Nina Cardinaels iD, Patrick Calders iD, Thierry Troosters iD, Eric Derom iD, Heleen Demeyer iD

JMIR mHealth and uHealth · 2024-11-06 · 12 · e56027-e56027

DOI: 10.2196/56027 ↗

Auf einen Blick

Bei 30 Patient:innen mit COPD und 25 gesunden Kontrollen zeigte die Fitbit Charge 4 meist eine moderate bis gute Übereinstimmung mit Referenzgeräten. Die Messwerte wichen jedoch teilweise von den Referenzgeräten ab.

Fragestellung

Wie valide ist die Fitbit Charge 4 zur Messung klinischer Parameter bei Patient:innen mit COPD und gesunden Kontrollen im Vergleich zu medizinischen Referenzgeräten?

Methode

Beobachtungsstudie in Belgien; Vergleich der Fitbit Charge 4 mit Dynaport MoveMonitor, Polar H10 und Nonin WristOX 2 3150 unter Alltagsbedingungen.

Ergebnisse

Gute Übereinstimmung für Schrittzahl, RHR und RR; HRV moderat bis stark, Sauerstoffsättigung bei COPD schlecht. Die Fitbit überschätzte Schrittzahl und unterschätzte HRV; RHR, RR und Sauerstoffsättigung waren teils überschätzt.

Schlussfolgerung der Autor:innen

Die Fitbit Charge 4 zeigte überwiegend moderate bis gute Übereinstimmung, die Messungen wichen aber von Referenzgeräten ab; die Fernüberwachung und Interpretation erfordern daher Vorsicht.

Kernaussagen

  • 30 Patient:innen mit COPD und 25 Kontrollen
  • Gute Übereinstimmung für Schrittzahl, RHR und RR
  • Oxygen saturation bei COPD nur schlechte Übereinstimmung

Deutsche Zusammenfassung: KI-gestützt aus dem Original-Abstract erstellt; alle Zahlen wurden automatisch mit dem Original abgeglichen. Maßgeblich ist der Original-Abstract.

At a glance

Beobachtungsstudie in JMIR mHealth and uHealth, published online on 2024-11-06. Written by Fien Hermans and 8 co-authors. Institution: Department of Rehabilitation Sciences, Ghent University, Corneel Heymanslaan 10, Entrance 46, Ghent, 9000, Belgium, 3293326915. Major MEDLINE topics: Pulmonary Disease, Chronic Obstructive, Wearable Electronic Devices. Cited 25 times so far (Crossref); 56 references. The full text is freely available in PubMed Central.

Auf einen BlickAstrattSubjectsDettalji biblijografiċiCiteRelated studies

Abstract (original language)

Background

Consumer-based wearables are becoming more popular and provide opportunities to track individual’s clinical parameters remotely. However, literature about their criterion and known-groups validity is scarce.

Objective

This study aimed to assess the validity of the Fitbit Charge 4, a wrist-worn consumer-based wearable, to measure clinical parameters (ie, daily step count, resting heart rate [RHR], heart rate variability [HRV], respiratory rate [RR], and oxygen saturation) in patients with chronic obstructive pulmonary disease (COPD) and healthy controls in free-living conditions in Belgium by comparing it with medical-grade devices.

Methods

Participants wore the Fitbit Charge 4 along with three medical-grade devices: (1) Dynaport MoveMonitor for 7 days, retrieving daily step count; (2) Polar H10 for 5 days, retrieving RHR, HRV, and RR; and (3) Nonin WristOX 2 3150 for 4 nights, retrieving oxygen saturation. Criterion validity was assessed by investigating the agreement between day-by-day measures of the Fitbit Charge 4 and the corresponding reference devices. Known-groups validity was assessed by comparing patients with COPD and healthy controls.

Results

Data of 30 patients with COPD and 25 age- and gender-matched healthy controls resulted in good agreement between the Fitbit Charge 4 and the corresponding reference device for measuring daily step count (intraclass correlation coefficient [ICC 2,1 ]=0.79 and ICC 2,1 =0.85, respectively), RHR (ICC 2,1 =0.80 and ICC 2,1 =0.79, respectively), and RR (ICC 2,1 =0.84 and ICC 2,1 =0.77, respectively). The agreement for HRV was moderate (healthy controls: ICC 2,1 =0.69) to strong (COPD: ICC 2,1 =0.87). The agreement in measuring oxygen saturation in patients with COPD was poor (ICC 2,1 =0.32). The Fitbit device overestimated the daily step count and underestimated HRV in both groups. While RHR and RR were overestimated in healthy controls, no difference was observed in patients with COPD. Oxygen saturation was overestimated in patients with COPD. The Fitbit Charge 4 detected significant differences in daily step count, RHR, and RR between patients with COPD and healthy controls, similar to those identified by the reference devices, supporting known-groups validity.

Conclusions

Although the Fitbit Charge 4 shows mainly moderate to good agreement, measures of clinical parameters deviated from the reference devices, indicating that monitoring patients remotely and interpreting parameters requires caution. Differences in clinical parameters between patients with COPD and healthy controls that were measured by the reference devices were all detected by the Fitbit Charge 4.

Subjects

MeSH terms (MEDLINE)

Pulmonary Disease, Chronic ObstructiveWearable Electronic DevicesHumansMaleFemaleMiddle AgedAgedBelgiumHeart RateReproducibility of ResultsCase-Control Studies

Author keywords

COPDFitbitchronic obstructive pulmonary diseaseclinical parametersdevicesheart rateheart rate variabilitymonitoringobservational studyoxygen saturationphysical activityrespiratory ratevaliditywearablewrist-worn wearable

Authors and institutions

  • Department of Rehabilitation Sciences, Ghent University, Corneel Heymanslaan 10, Entrance 46, Ghent, 9000, Belgium, 3293326915.
  • Department of Rehabilitation Sciences, KU Leuven, Leuven, Belgium.
  • Department of Chronic Diseases, Metabolism and Aging (CHROMETA) - BREATHE, KU Leuven, Leuven, Belgium.
  • Clinical Department of Respiratory Diseases, University Hospitals Leuven, Leuven, Belgium.
  • Clinical Department of Respiratory Medicine, Ghent University Hospital, Ghent, Belgium.

ORCID profiles: Fien Hermans, Eva Arents, Astrid Blondeel, Wim Janssens, Nina Cardinaels, Patrick Calders, Thierry Troosters, Eric Derom, Heleen Demeyer

Cite

APA

Hermans, F., Arents, E., Blondeel, A., Janssens, W., Cardinaels, N., Calders, P., Troosters, T., Derom, E., & Demeyer, H. (2024). Validity of a Consumer-Based Wearable to Measure Clinical Parameters in Patients With Chronic Obstructive Pulmonary Disease and Healthy Controls: Observational Study. JMIR mHealth and uHealth, 12, e56027-e56027. https://doi.org/10.2196/56027

Vancouver

Hermans F, Arents E, Blondeel A, Janssens W, Cardinaels N, Calders P, et al. Validity of a Consumer-Based Wearable to Measure Clinical Parameters in Patients With Chronic Obstructive Pulmonary Disease and Healthy Controls: Observational Study. JMIR mHealth and uHealth. 2024;12:e56027-e56027. doi:10.2196/56027

BibTeX
@article{Hermans2024,
  author = {Hermans, Fien and Arents, Eva and Blondeel, Astrid and Janssens, Wim and Cardinaels, Nina and Calders, Patrick and Troosters, Thierry and Derom, Eric and Demeyer, Heleen},
  title = {Validity of a Consumer-Based Wearable to Measure Clinical Parameters in Patients With Chronic Obstructive Pulmonary Disease and Healthy Controls: Observational Study},
  journal = {JMIR mHealth and uHealth},
  year = {2024},
  volume = {12},
  pages = {e56027--e56027},
  doi = {10.2196/56027}
}
Start for free →